Risk of fetal loss associated with invasive testing following combined first-trimester screening for Down syndrome: a national cohort of 147,987 singleton pregnancies.
about
Recent advances in prenatal genetic screening and testingThe maternal age-related first trimester risks for trisomy 21, 18 and 13 based on Danish first trimester data from 2005 to 2014.Management of suspected primary Toxoplasma gondii infection in pregnant women in Norway: twenty years of experience of amniocentesis in a low-prevalence population.Fetal Genotyping in Maternal Blood by Digital PCR: Towards NIPD of Monogenic Disorders Independently of Parental OriginPositive Attitudes towards Non-Invasive Prenatal Testing (NIPT) in a Swedish Cohort of 1,003 Pregnant WomenMaternal anxiety and its correlation with pain experience during chorion villus sampling and amniocentesis.The yield and complications of amniocentesis performed after 24 weeks of gestation.Genome-wide cfDNA screening: clinical laboratory experience with the first 10,000 cases.Preventing Congenital Cytomegalovirus Infection.Frequency of fetal karyotype abnormalities in women undergoing invasive testing in the absence of ultrasound and other high-risk indications.Impact of nationwide health insurance coverage for non-invasive prenatal testing.Total pregnancy loss after chorionic villus sampling and amniocentesis: a cohort study.Chorionic villus sampling in the cell-free DNA aneuploidy screening era: careful selection criteria can maximise the clinical utility of screening and invasive testing.Down Syndrome Screening in India: Are We There Yet?Women's preference for non-invasive prenatal DNA testing versus chromosomal microarray after screening for Down syndrome: a prospective study.Detection of a case of chronic myeloid leukaemia with deletions at the t(9;22) translocation breakpoints by a genome-wide non-invasive prenatal test.ISUOG Practice Guidelines: invasive procedures for prenatal diagnosis.Implications of fetoplacental mosaicism on cell-free DNA testing: a review of a common biological phenomenon.Danish Sonographers' Experiences of the Introduction of "Moderate Risk" in Prenatal Screening for Down Syndrome
P2860
Q28071888-B71F07F7-B841-4A8D-817E-B4BA1B22DB1AQ31089104-0B96067B-24AB-4A60-925D-8989CEECDACBQ33604441-CABF0B10-0475-4A0C-ABE8-C38507E6E80FQ35990077-0D72D0EF-DAD8-494D-B246-0B40A9B869CBQ36022080-A3018BF0-2042-4795-9077-50BB5C88BE59Q37709543-DDAD8622-A502-4A7E-BEAC-0EEA75B21D45Q38765977-E1BF87DE-4E95-4356-8BDD-A89AD201DD25Q39375461-3896C0F0-9B87-4D73-9D9B-1709F3577D55Q40086042-BFEEC606-8FE4-4021-98EE-D7D97BC9CE1CQ40524568-95560857-C0BB-419F-A218-878809D67E61Q47198619-7573AC15-BF3C-45B1-9A2B-99A0C1ECC168Q47779914-38F1C795-A8C1-47C9-86EB-D3A34BFD3499Q48227886-2A7F25DF-B5C6-4F40-B968-F74ED3D68C08Q48258894-A1B76EA7-C1E7-4C35-8D62-6FF5FB38FAB4Q50070985-3CD3F1CA-8810-4C71-959E-489A0C4C1F8FQ51706611-1FFF2A9A-2DDB-4B32-80CD-CC5FB4B31B84Q53046235-C9219A0F-7AED-4C2E-B31F-F2114F43752EQ53091843-AC94B41F-88C3-4288-BA47-B37463692309Q58578738-951EF1D9-2C88-4E79-8577-6777177F445A
P2860
Risk of fetal loss associated with invasive testing following combined first-trimester screening for Down syndrome: a national cohort of 147,987 singleton pregnancies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Risk of fetal loss associated ...... 147,987 singleton pregnancies.
@en
type
label
Risk of fetal loss associated ...... 147,987 singleton pregnancies.
@en
prefLabel
Risk of fetal loss associated ...... 147,987 singleton pregnancies.
@en
P2093
P2860
P50
P356
P1476
Risk of fetal loss associated ...... 147,987 singleton pregnancies
@en
P2093
Danish Fetal Medicine Study Group
O B Petersen
P2860
P356
10.1002/UOG.15820
P577
2016-01-01T00:00:00Z